RELATED NEWS
India's Decade: The Opportunity You Can't Afford to Miss
Ajay Garg, MD & Founder of Equirus Capital, made a compelling case for why India is becoming one of...
Life Sciences PE: The Misunderstood Opportunity
Christoph Broja, Partner at EQT, dismantled the myth that biotech is too risky for private...
Secondaries in 2026: The Active Allocator's Edge
Iyobosa Adeghe from Coller Capital, made the case for why sophisticated investors are increasingly...